Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells (2014)
- Authors:
- Machado Neto, João Agostinho - Universidade Estadual de Campinas (UNICAMP)
- Campos, Paula de Melo - Universidade Estadual de Campinas (UNICAMP)
- Favaro, Patricia - Universidade Estadual de Campinas (UNICAMP)
- Lazarini, Mariana - Universidade Estadual de Campinas (UNICAMP)
- Lorand-Metze, Irene - Universidade Estadual de Campinas (UNICAMP)
- Costa, Fernando Ferreira - Universidade Estadual de Campinas (UNICAMP)
- Saad, Sara Teresinha Olalla - Universidade Estadual de Campinas (UNICAMP)
- Traina, Fabiola
- Machado Neto, João Agostinho - Universidade Estadual de Campinas (UNICAMP)
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.leukres.2013.11.013
- Subjects: PROLIFERAÇÃO CELULAR; LEUCEMIA MIELOIDE AGUDA; CÉLULAS CULTIVADAS DE TUMOR
- Language: Inglês
- Imprenta:
- Publisher place: Kidlington
- Date published: 2014
- Source:
- Título: Leukemia Research
- ISSN: 0145-2126
- Volume/Número/Paginação/Ano: v. 38, n. 2, p. 251-257, 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MACHADO NETO, João Agostinho et al. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells. Leukemia Research, v. 38, n. 2, p. 251-257, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2013.11.013. Acesso em: 27 jan. 2026. -
APA
Machado Neto, J. A., Campos, P. de M., Favaro, P., Lazarini, M., Lorand-Metze, I., Costa, F. F., et al. (2014). Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells. Leukemia Research, 38( 2), 251-257. doi:10.1016/j.leukres.2013.11.013 -
NLM
Machado Neto JA, Campos P de M, Favaro P, Lazarini M, Lorand-Metze I, Costa FF, Saad STO, Traina F. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells [Internet]. Leukemia Research. 2014 ; 38( 2): 251-257.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1016/j.leukres.2013.11.013 -
Vancouver
Machado Neto JA, Campos P de M, Favaro P, Lazarini M, Lorand-Metze I, Costa FF, Saad STO, Traina F. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells [Internet]. Leukemia Research. 2014 ; 38( 2): 251-257.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1016/j.leukres.2013.11.013 - Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia
- IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients
- Hedgehog pathway is deregulated in myelodysplastic syndrome progenitor bone marrow cells
- Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome
- STMN1 (stathmin 1)
- Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms
- Differential profile of PIP4K2A expression in hematological malignancies
- FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
- MDR-1 and GST polymorphisms are involved in myelodysplasia progression
Informações sobre o DOI: 10.1016/j.leukres.2013.11.013 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
